A report by David Barboza of the New York Times details how an apparently highly-placed whistleblower in GlaxoSmithKline's China operation sent the head office in London a series of long, well-written memos about illegal sales practices that directors, executives, and auditors chose to ignore.
Entries in GlaxoSmithKline (35)
The Securities and Exchange Commission said Friday UK-based pharma GlaxoSmithKline plc will pay a $20 million civil penalty to settle charges that it violated the Foreign Corrupt Practices Act when China-based subsidiaries spent millions of dollars on pay-to-prescribe schemes for several years to pump up sales.
The U.S. Attorney’s Office for the Eastern District of Pennsylvania filed an indictment Wednesday charging five people in an alleged scheme to steal trade secrets from pharma giant GlaxoSmithKline.
You might expect corrupt companies to downplay and devalue the principles of market competition. In fact the opposite is true.
British investigator Peter Humphrey and his American wife Yu Yingzeng have been released early from prison in China.
China is pushing reforms at public hospitals in the wake of widespread complaints about inadequate healthcare services and corruption related to drug sales.
A new phase has begun in the maturation of China as an economic superpower, an era that President Xi Jinping has taken to calling “the new normal.” The ongoing challenge for Beijing is to transition from a largely investment-propelled, export-oriented economy to one increasingly driven by consumption.
Let's go straight to some news from beyond America's shores during the past year.
Qualcomm Inc. agreed to pay a fine of $975 million to regulators in China. The biggest corporate fine in the country's history resolves a 14-month investigation for anti-competitive practices.
China’s state-run newspaper People’s Daily has accused multinational companies of avoiding taxes in China and urged authorities to take measures to combat tax evasion.
An executive at Swiss pharma Novartis pleaded guilty in a bribery prosecution in Poland, the company has confirmed.